1. Home
  2. MITT vs MDWD Comparison

MITT vs MDWD Comparison

Compare MITT & MDWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MITT
  • MDWD
  • Stock Information
  • Founded
  • MITT 2011
  • MDWD 2000
  • Country
  • MITT United States
  • MDWD Israel
  • Employees
  • MITT N/A
  • MDWD N/A
  • Industry
  • MITT Real Estate Investment Trusts
  • MDWD Medicinal Chemicals and Botanical Products
  • Sector
  • MITT Real Estate
  • MDWD Health Care
  • Exchange
  • MITT Nasdaq
  • MDWD Nasdaq
  • Market Cap
  • MITT 230.0M
  • MDWD 208.2M
  • IPO Year
  • MITT 2011
  • MDWD 2014
  • Fundamental
  • Price
  • MITT $7.70
  • MDWD $17.84
  • Analyst Decision
  • MITT Strong Buy
  • MDWD Strong Buy
  • Analyst Count
  • MITT 5
  • MDWD 2
  • Target Price
  • MITT $8.50
  • MDWD $35.00
  • AVG Volume (30 Days)
  • MITT 155.0K
  • MDWD 156.4K
  • Earning Date
  • MITT 11-04-2025
  • MDWD 08-14-2025
  • Dividend Yield
  • MITT 10.89%
  • MDWD N/A
  • EPS Growth
  • MITT N/A
  • MDWD N/A
  • EPS
  • MITT 0.86
  • MDWD N/A
  • Revenue
  • MITT $83,509,000.00
  • MDWD $19,858,000.00
  • Revenue This Year
  • MITT N/A
  • MDWD $20.37
  • Revenue Next Year
  • MITT $14.05
  • MDWD $25.91
  • P/E Ratio
  • MITT $8.99
  • MDWD N/A
  • Revenue Growth
  • MITT 25.02
  • MDWD N/A
  • 52 Week Low
  • MITT $5.63
  • MDWD $14.14
  • 52 Week High
  • MITT $7.95
  • MDWD $22.51
  • Technical
  • Relative Strength Index (RSI)
  • MITT 54.72
  • MDWD 51.00
  • Support Level
  • MITT $7.62
  • MDWD $16.08
  • Resistance Level
  • MITT $7.82
  • MDWD $20.30
  • Average True Range (ATR)
  • MITT 0.12
  • MDWD 0.95
  • MACD
  • MITT 0.02
  • MDWD 0.26
  • Stochastic Oscillator
  • MITT 64.71
  • MDWD 41.71

About MITT AG Mortgage Investment Trust Inc.

AG Mortgage Investment Trust Inc is a real estate investment trust (REIT). It focuses on investing in a diversified risk-adjusted portfolio of residential mortgage-related assets in the U.S. mortgage market. Its objective is to provide attractive risk-adjusted returns to its stockholders over the long term through dividends and capital appreciation. It also focuses on investing in residential mortgage-backed securities (RMBS) issued or guaranteed by a government-sponsored enterprise.

About MDWD MediWound Ltd.

MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds, and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.

Share on Social Networks: